233 OHIP code: Carcinoma in Situ: Breast and genito-urinary system
233 is the OHIP diagnostic code for “Carcinoma in Situ: Breast and genito-urinary system” in Ontario Ministry of Health’s March 2026 release, in effect from Mar 13, 2026.
Official description
233Carcinoma in Situ: Breast and genito-urinary system
OHIP diagnostic codes (ICD-9) · Ontario
Notes for 233
Ontario Ministry of Health’s list gives no includes, excludes or other notes for 233 or the headings above it.
Where 233 sits
- 1SectionNeoplasms
- 2Valid code 233Carcinoma in Situ: Breast and genito-urinary system
Source and release
- Data release
- OHIP · March 2026
- Effective date
- Mar 13, 2026
- Publisher
- Ontario Ministry of Health
This page is built from the OHIP catalog that Vero Codes reads when it suggests codes: Ontario Ministry of Health’s March 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does OHIP diagnostic code 233 mean?
233 is the OHIP diagnostic code for “Carcinoma in Situ: Breast and genito-urinary system” in Ontario Ministry of Health’s OHIP March 2026 release.
Where is 233 in the OHIP list?
233 is listed under Neoplasms.
What coding notes apply to 233?
Ontario Ministry of Health’s list gives no includes, excludes or other notes for 233 or the headings above it.
Which OHIP release does this page use?
It uses Ontario Ministry of Health’s March 2026 release, in effect from Mar 13, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.